Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.

In this episode Tim chats with Michael Johnson, executive director and CEO of Rhinomed (ASX:RNO).

Rhinomed is an airway technology company focused on improving patient breathing, sleeping, health and medication intake.

The company’s nasal technology leverages the physiology of the nose to optimise breathing, which it also believes could have efficacy in the delivery of medicines and other therapeutic treatments.

Rhinomed’s share price soared in mid September after the company announced development of a new virus nasal swab.

So tune in below to hear the pair discuss all things nasal swabs, drug delivery and RNO’s year ahead.

On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.

Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!